Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
94.8M
-
Shares change
-
+6.71M
-
Total reported value, excl. options
-
$57.2M
-
Value change
-
+$5.27M
-
Put/Call ratio
-
0.84
-
Number of buys
-
27
-
Number of sells
-
-40
-
Price
-
$0.60
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q3 2025
94 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q3 2025.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94.8M shares
of 144M outstanding shares and own 65.97% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (21.4M shares), Vestal Point Capital, LP (14.3M shares), Propel Bio Management, LLC (11.3M shares), Knoll Capital Management, LLC (7.8M shares), VANGUARD GROUP INC (5.1M shares), Simplify Asset Management Inc. (4.49M shares), BlackRock, Inc. (3.84M shares), PNC Financial Services Group, Inc. (2.9M shares), Pathstone Holdings, LLC (2.64M shares), and MARSHALL WACE, LLP (2.54M shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.